Royal Bank of Canada’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.84M Buy
345,898
+345,685
+162,293% +$4.83M ﹤0.01% 2362
2025
Q1
$3K Sell
213
-3,436
-94% -$48.4K ﹤0.01% 6147
2024
Q4
$70K Sell
3,649
-2,772
-43% -$53.2K ﹤0.01% 5050
2024
Q3
$146K Buy
6,421
+236
+4% +$5.37K ﹤0.01% 4628
2024
Q2
$81K Buy
6,185
+4,399
+246% +$57.6K ﹤0.01% 5010
2024
Q1
$32K Sell
1,786
-11,324
-86% -$203K ﹤0.01% 5276
2023
Q4
$286K Buy
13,110
+7,242
+123% +$158K ﹤0.01% 4259
2023
Q3
$90K Buy
5,868
+2,669
+83% +$40.9K ﹤0.01% 4969
2023
Q2
$76K Buy
3,199
+1,049
+49% +$24.9K ﹤0.01% 5095
2023
Q1
$54K Sell
2,150
-2,123
-50% -$53.3K ﹤0.01% 5206
2022
Q4
$124K Buy
4,273
+3,950
+1,223% +$115K ﹤0.01% 4829
2022
Q3
$7K Buy
323
+177
+121% +$3.84K ﹤0.01% 6126
2022
Q2
$2K Sell
146
-6,791
-98% -$93K ﹤0.01% 6537
2022
Q1
$128K Buy
+6,937
New +$128K ﹤0.01% 4996
2020
Q4
Hold
0
6690
2020
Q3
Sell
-52
Closed -$1K 6373
2020
Q2
$1K Hold
52
﹤0.01% 6010
2020
Q1
$0 Buy
+52
New ﹤0.01% 6343
2019
Q4
Sell
-2
Closed 6369
2019
Q3
$0 Buy
+2
New ﹤0.01% 6191
2018
Q4
Sell
-40
Closed -$3K 6138
2018
Q3
$3K Buy
40
+24
+150% +$1.8K ﹤0.01% 5834
2018
Q2
$2K Buy
16
+9
+129% +$1.13K ﹤0.01% 5690
2018
Q1
$1K Hold
7
﹤0.01% 5618
2017
Q4
$1K Sell
7
-66
-90% -$9.43K ﹤0.01% 5670
2017
Q3
$10K Buy
73
+72
+7,200% +$9.86K ﹤0.01% 5516
2017
Q2
$0 Buy
+1
New ﹤0.01% 5951